Cited by 162Nutrition and Health in AgingBody Composition Measurement TechniquesFrailty in Older Adults

Clinical implications of sarcopenic obesity in cancer

Carneiro, Isabella P., Mazurak, Vera C., Prado, Carla M.·2016·Current Oncology Reports

Abstract

Sarcopenia has been associated with several negative clinical outcomes in cancer. However, the consequences of sarcopenic obesity, a condition of combined sarcopenia and obesity burden, have been less extensively investigated. The aim of this paper was to review the current evidence on the prevalence and clinical implications of sarcopenic obesity in cancer. A total of 14 studies linking sarcopenic obesity to a clinical outcome in cancer were included. There is considerable inconsistency in methods used to evaluate body composition as well as in the criteria used to define sarcopenic obesity, which limits comparison among studies. Therefore, the prevalence of sarcopenic obesity varied substantially: between 1 and 29 % in studies including individuals from all body mass index categories and between 15 and 36 % for those including obese individuals only. Negative clinical outcomes reported to be associated with sarcopenic obesity included higher risk of dose-limiting toxicity, surgical complications, physical disability, and shorter survival.

Integrity signals

Registry

Crossref · 10.1007/s11912-016-0546-5

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adverse clinical cancer outcomes are reported to be relevant to sarcopenic obesity, especially with respect to dose-limiting toxicity, surgical complications, physical disability, and shorter survival.

    “Moreover, adverse clinical cancer outcomes reported to be relevant to SO, especially with respect to dose-limiting toxicity, surgical complications, physical disability, and shorter survival (59–61).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carneiro, I. P., Mazurak, V. C., & Prado, C. M.
Affiliations
University of Alberta (CA)
Corresponding author
Prado, Carla M.
Venue
Current Oncology Reports
Published
2016-08-19
Volume
18
Issue
10
Pages
62-62
ISSN
  • 1523-3790 (ISSN-L)
  • 1534-6269
OpenAlex
W2518082324
Cited by
162
References
77
Citations by year
2026: 9 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 15 · 2021: 23 · 2020: 22 · 2019: 19 · 2018: 17 · 2017: 9 · 2016: 1
FWCI
1.80
Type
journal article
Language
en
Open access
closed
Locations
  • Current Oncology Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Physiology › Body Composition Measurement Techniques
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
Keywords
sarcopenic obesity, sarcopenia, obesity, cancer, body composition, prevalence, dose-limiting toxicity, surgical complications, physical disability, survival, clinical outcomes
MeSH terms
Antineoplastic Combined Chemotherapy Protocols, Body Composition, Dose-Response Relationship, Drug, Humans, Neoplasms, Obesity, Prevalence, Survival Analysis, Treatment Outcome, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review